Novo Seeds Portfolio Company Galecto Raises USD 64 Million To Accelerate Development Of Clinical Pipeline
COPENHAGEN, Denmark, Sept. 25, 2020 /PRNewswire/ -- Novo Seeds, the early stage investment and company creation team of Novo Holdings, today announced that its portfolio company Galecto Inc. (Galecto), a privately-held biotechnology company focused on the development of novel treatments...
Holidu has been winning the pandemic. It has become profitable thanks to a surge of interest in vacation rentals and holiday homes. Plus, other startup funding news. -Sean O'Neill.
Here's a bright ray of positivity in a gloomy time. Howzat is raising a big fund, and it plans to make roughly half of its investments in travel and transportation startups. -Sean O'Neill.
TEL AVIV, Israel, September 15, 2020-- Hetz Ventures, a leading venture capital fund for early-stage investments, announced today the close of its second flagship fund, oversubscribed at $77 million. Fully raised during the COVID-19 crisis, the fund had its first close in April and final close in July. With Fund II, Hetz will manage over $130M total. The firm closed Fund I of $55 million in February 2018 and, leveraging its deep network of Israeli entrepreneurs and international enterprises, has since invested in 10 companies in various enterprise software verticals.
Crista Galli Ventures Outs 'evergreen' Fund To Back European Health Tech Startups At Seed And Series A - Techcrunch
Crista Galli Ventures, an early-stage health tech fund in Europe, is officially launching today. The firm offers "patient capital" -- with only a single LP (the Danish family office IPQ Capital) -- and promises to provide portfolio companies with deep healthcare expertise and the extra runway needed to get over regulatory and efficacy hurdles and [...]
Neogene Therapeutics Raises $110M Series A Financing To Develop Next-generation Fully Personalized Neo-antigen T Cell Receptor (tcr) Therapies
Neogene Therapeutics Raises $110 Million Series A Financing to Develop Next-Generation Fully Personalized Neo-Antigen T Cell Receptor (TCR) Therapies Series A Financing led by EcoR1 Capital, Jeito Capital and Syncona with continued support of strategic seed investors Vida Ventures, TPG and Two River Neogene's proprietary technology platform identifies specific T cell receptor (TCR) genes from routine tumor samples using state-of-the-art synthetic biology tools Co-founded by renowned T cell engineering expert Ton Schumacher, Ph.D. and Carsten Linnemann, Ph.D. with investment from cell therapy industry veteran Arie Belldegrun, M.D.
I spoke with PayPal alumni Vilash Poovala about raising the largest seed investment in Latin America and the opportunities in fintech.
The Bengaluru-based platform wants to strengthen its tech, product and engineering segments . Part of the money will be utilised to power an educational initiative about financial markets across India. This is YC Continuity's first investment in India.
Deel Raises $30M In Series B Funding To Break The Confines Of Geographically-concentrated Workforces, Enabling Businesses To Legally Hire Anyone, Anywhere In The World | Business Wire
SAN FRANCISCO--(BUSINESS WIRE)--Deel Raises $30 Million in Series B Funding Enabling Businesses to Legally Hire Anyone, Anywhere. : SAN FRANCISCO--(BUSINESS WIRE)--Deel, a payroll and compliance platform for international teams, today announced it has raised $30 million in Series B funding, led by Spark Capital. The investment closely follows a $14M Series A round, closed in May, led by Andreessen Horowitz. Deel's total funding now exceeds $48 million, including seed investment and participation from YC Growth Fund and notable angel investors including Nat Friedman, Ryan Petersen, John Zimmer, William Hockey and Alexis Ohanian.
Fund II will invest Rs 3-10 crore per round in emerging deeptech startups. The post India: StartupXseed launches $26.6m second fund to invest in deeptech firms appeared first on DealStreetAsia.